Ren Feng
Directeur Général chez InSilico Medicine Hong Kong Ltd.
Profil
Ren Feng is currently the Co-CEO, Chief Scientific Officer & Director at InSilico Medicine Hong Kong Ltd.
He holds a doctorate degree from Harvard University.
Postes actifs de Ren Feng
| Sociétés | Poste | Début |
|---|---|---|
InSilico Medicine Hong Kong Ltd.
 InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | Directeur Général | 15/06/2022 |
Formation de Ren Feng
| Harvard University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
InSilico Medicine Hong Kong Ltd.
InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | Technology Services |
